Sie sind bereits eingeloggt. Klicken Sie auf 2. tolino select Abo, um fortzufahren.
Bitte loggen Sie sich zunächst in Ihr Kundenkonto ein oder registrieren Sie sich bei bücher.de, um das eBook-Abo tolino select nutzen zu können.
Current heart failure therapeutics affects symptoms without appreciably reducing the mortality rate of 50% in five years -- suggesting a failure in treating the underlying mechanism. This book proposes a new mechanism for heart failure; immune mediated cardiac remodelling for cardiac dysfunction. The outstanding editor team of two internationally recognized immunologists -- Ronald Watson, who has studied heart disease in immune dysfunction for a decade and has a patent for an immunotherapy of heart disease by immune regulation, and Douglas Larson, whose experience in cardiac transplantation…mehr
Current heart failure therapeutics affects symptoms without appreciably reducing the mortality rate of 50% in five years -- suggesting a failure in treating the underlying mechanism. This book proposes a new mechanism for heart failure; immune mediated cardiac remodelling for cardiac dysfunction. The outstanding editor team of two internationally recognized immunologists -- Ronald Watson, who has studied heart disease in immune dysfunction for a decade and has a patent for an immunotherapy of heart disease by immune regulation, and Douglas Larson, whose experience in cardiac transplantation immunology has provided the foundation for research into novel therapeutics for heart failure and hypertension - makes Immune Dysfunction and Immunotherapy in Heart Disease the definitive reference to the state of the science in this area. The four parts of the book address: * * Immune Dysfunction Leading to Heart Disease: Induction by Physiological Changes * Immune Dysfunction Promoting CVD: Induction by Transplantation Drugs * Immune Dysfunction Leading to Heart Dysfunction: Induction or Prevention by Cardiotherapeutic Drugs * Immune Dysfunction Leading to Heart Disease: Induction by Pathogens Both researchers and practitioners will find this authoritative volume an excellent source of information on novel immune targeted therapeutics.
Dieser Download kann aus rechtlichen Gründen nur mit Rechnungsadresse in A, B, BG, CY, CZ, D, DK, EW, E, FIN, F, GR, HR, H, IRL, I, LT, L, LR, M, NL, PL, P, R, S, SLO, SK ausgeliefert werden.
Die Herstellerinformationen sind derzeit nicht verfügbar.
Autorenporträt
Dr. Larson and Dr. Watson have worked together researching the role of immune and cytokine dysfunction in heart disease for 8 years. They have been and currently are funded to do such research by grants from the U.S. National Institute of Heart, Lung and Blood, the American Heart Foundation, companies and private foundations. Dr. Watson has edited 62 scientific books, including several dealing with heart disease and conditions such as aging and AIDS that promote immune dysfunction as well as heart disease. Dr. Larson directs the Center's organ perfusion program as well as its Master degree in pharmacology and toxicology for perfusion students. ____________________________________________________________________ Ronald Ross Watson Ph.D. Professor Health Promotion Sciences, Mel and Enid Zuckerman College of Public Health and the Sarver Heart Center in the School of Medicine, University of Arizona, P. O. Box 245155, 1501 N. Campbell Avenue, Tucson, AZ 85749. (520) 626 2850, Fax (520) 626 6093 rwatson@u.arizona.edu ____________________________________________________________________ Douglas F. Larson Ph.D. Professor Surgery and the Sarver Heart Center in the School of Medicine, University of Arizona, P. O. Box 245066, 1501 N. Campbell Avenue, Tucson, AZ 85749. (520) 626 6494 dflarson@email.arizona.edu
Inhaltsangabe
PART 1: Immune Dysfunction Leading to Heart Disease: Induction by Physiological Changes
01 Immunosuppression by Ultraviolet Light-B Radiation: a Mediator of Cardiac Remodeling
02 Immune Mechanisms In Pediatric Cardiovascular Disease
03 Heart failure - role of autoimmunity
04 Immune basis of Hypertension in Humans
05 Immune Dysregulation: Potential Mediator of Metabolic Syndrome-Induced Cardiac Remodeling
06 T-Helper 2 Cell Cytokines In Remodelling Of Aortic Wall
07 Effects of TNF-alpha on Cardiac Function
08 Immunosuppression in Promotion of Cardiac Allograft Vasculopathy
09 Immunotherapy for left ventricular dysfunction after heart transplantation
PART 2: Immune Dysfunction Promoting CVD: Induction by Transplantation Drugs
10 Immunmodulating therapy in chronic heart failure
11 Statins in Atherosclerosis: Role of Immune Regulation
12 ACE Inhibitors as Immunmodulators: Treatment of Cardiovascular Disease
13 Treatment of Heart Failure by Anticytokine Therapies
PART 3: Immune Dysfunction Leading to Heart Dysfunction: Induction or prevention by Cardiotherapeutic Drugs
14 Pathogenesis Of Cardiovascular Complications In The Acquired Immunodeficiency Syndrome
15 Cytokines and T cell-Mediated Responses in Autoimmune Myocarditis
16 Drugs of abuse: Accentuation of immunomodulation of viral myocarditis
PART 4: Immune Dysfunction Leading to Heart Disease: Induction by Pathogens
17 Osteopontin: The link between the Immune System and cardiac remodeling
18 Inflammatory immune activation in heart failure patients; Therapeutic implications
19 Role of Innate Immune Dysregulation in Diabetic Heart Failure
20 Tolerance in Heart Transplantation: Current and Future Role
21 Neutralization of Th2 cytokines in therapy of cardiovascular pathology
22 Anti-inflammatory immune therapy in heart disease
23 Cholesterol Synthesis, Interleukin 6 inflammation and Atherosclerosis - Role of statins, bisphosphonates and plant polyphenols in Atherosclerosis and other diseases of Aging
24 Autoimmune myocarditis. Treatment with anti-T-cell antibodies
25 Immunosuppressive Therapy To Counter Cardiac Allograft Vasculopathy
26 Immunosuppression by Ultraviolet Light-B Radiation: a Mediator of Cardiac Remodeling
27 Role of oral pathogens in the pathogenesis of coronary heart disease
28 Myocardial regenerative potential by stem cell transplant
29 Bioflavanoids and Dietary Anti-Inflammatory Actions: Role in Cardiovascular Diseases
PART 1: Immune Dysfunction Leading to Heart Disease: Induction by Physiological Changes
01 Immunosuppression by Ultraviolet Light-B Radiation: a Mediator of Cardiac Remodeling
02 Immune Mechanisms In Pediatric Cardiovascular Disease
03 Heart failure - role of autoimmunity
04 Immune basis of Hypertension in Humans
05 Immune Dysregulation: Potential Mediator of Metabolic Syndrome-Induced Cardiac Remodeling
06 T-Helper 2 Cell Cytokines In Remodelling Of Aortic Wall
07 Effects of TNF-alpha on Cardiac Function
08 Immunosuppression in Promotion of Cardiac Allograft Vasculopathy
09 Immunotherapy for left ventricular dysfunction after heart transplantation
PART 2: Immune Dysfunction Promoting CVD: Induction by Transplantation Drugs
10 Immunmodulating therapy in chronic heart failure
11 Statins in Atherosclerosis: Role of Immune Regulation
12 ACE Inhibitors as Immunmodulators: Treatment of Cardiovascular Disease
13 Treatment of Heart Failure by Anticytokine Therapies
PART 3: Immune Dysfunction Leading to Heart Dysfunction: Induction or prevention by Cardiotherapeutic Drugs
14 Pathogenesis Of Cardiovascular Complications In The Acquired Immunodeficiency Syndrome
15 Cytokines and T cell-Mediated Responses in Autoimmune Myocarditis
16 Drugs of abuse: Accentuation of immunomodulation of viral myocarditis
PART 4: Immune Dysfunction Leading to Heart Disease: Induction by Pathogens
17 Osteopontin: The link between the Immune System and cardiac remodeling
18 Inflammatory immune activation in heart failure patients; Therapeutic implications
19 Role of Innate Immune Dysregulation in Diabetic Heart Failure
20 Tolerance in Heart Transplantation: Current and Future Role
21 Neutralization of Th2 cytokines in therapy of cardiovascular pathology
22 Anti-inflammatory immune therapy in heart disease
23 Cholesterol Synthesis, Interleukin 6 inflammation and Atherosclerosis - Role of statins, bisphosphonates and plant polyphenols in Atherosclerosis and other diseases of Aging
24 Autoimmune myocarditis. Treatment with anti-T-cell antibodies
25 Immunosuppressive Therapy To Counter Cardiac Allograft Vasculopathy
26 Immunosuppression by Ultraviolet Light-B Radiation: a Mediator of Cardiac Remodeling
27 Role of oral pathogens in the pathogenesis of coronary heart disease
28 Myocardial regenerative potential by stem cell transplant
29 Bioflavanoids and Dietary Anti-Inflammatory Actions: Role in Cardiovascular Diseases
Es gelten unsere Allgemeinen Geschäftsbedingungen: www.buecher.de/agb
Impressum
www.buecher.de ist ein Internetauftritt der buecher.de internetstores GmbH
Geschäftsführung: Monica Sawhney | Roland Kölbl | Günter Hilger
Sitz der Gesellschaft: Batheyer Straße 115 - 117, 58099 Hagen
Postanschrift: Bürgermeister-Wegele-Str. 12, 86167 Augsburg
Amtsgericht Hagen HRB 13257
Steuernummer: 321/5800/1497
USt-IdNr: DE450055826